#LanAnhHandmade #youtube My name is Lan Anh, owner of youtube channel LanAnhHandmade. I live in Vietnam, a country in ...

Dr. Berenika Maciejewicz, a triple-doctor and an expert in longevity, leads the company’s interdisciplinary team to ...

The Open University of Kenya has announced 61 job opportunities for academic and administrative staff positions. In a notice ...

After five years, Nido Biosciences has reached the end of the road, closing its doors after its lead neurological disease candidate disappointed in a midstage study. Founded by 5AM Ventures’ 4:59 ...

The performance metrics speak volumes. The iShares Biotechnology ETF (NASDAQ: IBB) has climbed 29.51% year to date through December 29, while the State Street SPDR S&P Biotech ETF (NASDAQ: XBI) has ...

Small and mid-cap biotech stocks entered 2025 like a compressed spring, and it finally snapped higher. “Biotech was a coiled spring following several quarters of underperformance,” Dr. Terry Smith, ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Thousands of workers lost their ...

The President claimed in a rare primetime Oval Office address that the economy is doing well and will boom in 2026. Will it persuade the public? Plus Paul Gigot and Matthew Continetti on Trump's best ...

2025 market gains were strong but heavily concentrated in megacap tech, setting up a potential 2026 rotation toward broader participation. I expect a neutral-to-slightly positive 2026 for SPY, with ...

On December 24, Jared Holz of Mizuho joined ‘Power Lunch’ on CNBC to talk about how to play biotech moving into 2026. Holz noted that healthcare has become the top-performing sector over the last 3 ...

CAMBRIDGE, Mass.—Jeremy Liew, 31 years old, moved to Boston from New Jersey in 2018 to study for a Ph.D. in chemistry and, he hoped, a career in the city’s bustling biotech industry. But after earning ...

Shares of both Ultragenyx and Mereo BioPharma were seeing record selloffs after disappointing trial results for setrusumab Shares of Ultragenyx and Mereo BioPharma were rocked by disappointing ...